Loading...
Radi by sme, aby ste sa stali súčasťou našej komunity. Pripojte sa k nášmu Discordu pre spojenie s nami a ostatnými členmi!
- Ticker
- NSIS-B.CO
- Price
- 471.20
- Stock movement down
- -1.30 (-0.31%)
- Company name
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Basic Materials >Specialty Chemicals
- Trhová kapitalizácia
- 172.65B
- Hodnota ent
- -
- Cena/Predaje
- -
- Cena/Účtovná hodnota
- -
- Výnos dividend
- 1.91%
- Rast dividend
- -
- Roky rastu
- -
- Výplata FCF
- -
- Koncové P/E
- -
- Vyprojektované P/E
- 26.27
- PEG
- -
- Rast EPS
- -
- 1 ročná návratnosť
- -3.61%
- 3 ročná návratnosť
- -3.24%
- 5 ročná návratnosť
- 1.81%
- 10 ročná návratnosť
- 1.96%
Naposledy aktualizované: 2025-09-17
DIVIDENDY
NSIS-B.CO nevypláca dividendy alebo neboli prijaté žiadne údaje
VALUÁCIE
Pomery valuácie
Loading...
Údaje o pomeroch valuácie
| Koncové P/E | - |
| Cena k OCF | - |
| Cena k FCF | - |
| Cena k EBITDA | - |
| EV k EBITDA | - |
Ocenenie (predaj/účtovná hodnota)
Loading...
Údaje o valuácii (predaj/účtovná hodnota).
| Cena k Predajom | - |
| Cena k účtovnej hodnote | - |
| EV k Predajom | - |
FINANCIE
INFORMÁCIE O AKCIÁCH
Akciové grafy
Loading...
Údaje o cene akcií
| Otvoriť | 419.80 |
| Denné maximum | 424.30 |
| Denné minimum | 417.60 |
| Denný objem | 593K |
| Historické maximum | 537.20 |
| 1 ročný odhad analytikov | - |
| Beta | - |
| EPS (TTM) | - |
| Dividenda na akciu | 8.00 |
| Dátum ex-div | 21 Aug 2025 |
| Ďalší dátum zárobkov | - |
Potenciál poklesu ceny
Loading...
Údaje o potenciáli poklesu ceny
| NSIS-B.CO | S&P500 | |
| Aktuálny pokles ceny proti historickému maximu | -21.97% | -1.06% |
| Najvyšší pokles ceny | -52.86% | -56.47% |
| Dátum najvyššieho poklesu | 27 Oct 2008 | 9 Mar 2009 |
| Priemerný pokles z maxima | -14.21% | -10.99% |
| Priemerný čas k novému maximumu | 23 days | 12 days |
| Maximálny čas k novému maximumu | 1127 days | 1805 days |
PODROBNOSTI O SPOLOČNOSTI
Trhová kapitalizácia
172.65B
Kategória trhovej kapitalizácie
Large-cap
Popis
Zamestnanci
Vzťahy s investormi
-
SEC podania
CEO
Krajina
Mesto
Typ akcie
-
CCC status
-
Dividendová frekvencia
-
PODUJATIA A PREZENTÁCIE
UdalostiPrezentácie
Loading...
POROZUMIEŤ PODNIKU
Loading...
NOVINKY O SPOLOČNOSTI
Všetky novinkyTlačové správy
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world’s best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the ...
23. októbra 2025
Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step...
21. októbra 2025
Manufacturing Day at Novonesis Tue Micheelsen, President, Novonesis North America and Carolyn Lee, President & Executive Director of the Manufacturing Institute accompany students on a Novonesis tour ...
6. októbra 2025
Novozymes (CPSE:NSIS B) might not be grabbing headlines with earth-shaking news right now, but that doesn’t mean investors should overlook what’s happening under the surface. Even modest moves can sig...
9. septembra 2025
Novonesis and Novo Nordisk have announced a research partnership to explore how the gut microbiome influences metabolic health, aiming to develop synbiotic food supplements and identify novel health b...
8. septembra 2025
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – Septemb...
8. septembra 2025
Corbion’s Supervisory Board announces it has nominated Per Falholt for appointment to the Supervisory Board for a term of four years as of the Annual General Meeting of Shareholders (AGM) in May 2026....
26. augusta 2025
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. Ester Baiget, President & CEO: “I’m very pleased with 9% organic ...
21. augusta 2025
9% organic sales growth in H1 and FY outlook range narrowed to 6-8% Ester Baiget, President & CEO: “I’m very pleased with 9% organic sales growth in the first half of the year. Demand for our biosolut...
21. augusta 2025
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its ‘GROW’ strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and signi...
20. augusta 2025
Ďalšia strana